Trial · NCT04152200
Adverse events150
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 150
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Swelling | General disorders | Cohort A: Lumasiran | 0 | 6 | |
| other | Swelling | General disorders | Cohort B: Lumasiran | 1 | 15 | |
| other | Cholelithiasis | Hepatobiliary disorders | Cohort A: Lumasiran | 0 | 6 | |
| other | Cholelithiasis | Hepatobiliary disorders | Cohort B: Lumasiran | 1 | 15 | |
| other | Candida nappy rash | Infections and infestations | Cohort A: Lumasiran | 1 | 6 | |
| other | Candida nappy rash | Infections and infestations | Cohort B: Lumasiran | 0 | 15 | |
| other | Catheter site infection | Infections and infestations | Cohort A: Lumasiran | 0 | 6 | |
| other | Catheter site infection | Infections and infestations | Cohort B: Lumasiran | 1 | 15 | |
| other | Clostridium difficile colitis | Infections and infestations | Cohort A: Lumasiran | 0 | 6 | |
| other | Clostridium difficile colitis | Infections and infestations | Cohort B: Lumasiran | 1 | 15 | |
| other | Conjunctivitis | Infections and infestations | Cohort A: Lumasiran | 0 | 6 | |
| other | Conjunctivitis | Infections and infestations | Cohort B: Lumasiran | 1 | 15 | |
| other | Device related infection | Infections and infestations | Cohort A: Lumasiran | 0 | 6 | |
| other | Device related infection | Infections and infestations | Cohort B: Lumasiran | 2 | 15 | |
| other | Ear infection | Infections and infestations | Cohort A: Lumasiran | 0 | 6 | |
| other | Ear infection | Infections and infestations | Cohort B: Lumasiran | 1 | 15 | |
| other | Paronychia | Infections and infestations | Cohort A: Lumasiran | 0 | 6 | |
| other | Paronychia | Infections and infestations | Cohort B: Lumasiran | 1 | 15 | |
| other | Roseola | Infections and infestations | Cohort A: Lumasiran | 0 | 6 | |
| other | Roseola | Infections and infestations | Cohort B: Lumasiran | 1 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04152200/events?page=2